DUBLIN--(BUSINESS WIRE)--Maven Semantic (http://www.mavensemantic.com) announces updates to their Atypical Actives research database.
Search Over 29,000 People and Over 2,000 Research Organisations
"Atypical Actives are chemicals that do not have an obvious medical function and yet have been designated as the API in marketing authorization. These Atypical Actives may not always be manufactured according to ICH Q7 because they are intended for use in other industrial sectors."
The new database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.
The database currently tags 29,000 individuals working in Atypical Actives. http://bit.ly/fe39V0.
Top 10 Countries for Atypical Actives Research (ranked by number of senior researchers)
- United States Of America (10,866)
- Japan (2,450)
- Germany (1,803)
- Italy (1,616)
- United Kingdom (1,518)
- France (1,392)
- Canada (863)
- Spain (595)
- Australia (496)
- China (463)
Leading organisations in Atypical Actives research include:
- Albert Einstein College of Medicine
- All India Institute of Medical Sciences
- Armed Forces Institute of Pathology
- Baylor College of Medicine
- Beth Israel Deaconess Medical Center
- Brigham and Women's Hospital
- Centers for Disease Control and Prevention
- Children's Hospital
- Cleveland Clinic Foundation
- Cornell University
- Dana-Farber Cancer Institute
- Fred Hutchinson Cancer Research Center
- Harvard Medical School
- Howard Hughes Medical Institute
- Indiana University School of Medicine
- Institut Pasteur
- Johns Hopkins University School of Medicine
- Karolinska Institute
- Massachusetts General Hospital
- Mayo Clinic College of Medicine
- Memorial Sloan-Kettering Cancer Center
- National Cancer Institute
- National Institute of Mental Health
- Polish Academy of Sciences
- Prince of Wales Hospital
- Roswell Park Cancer Institute
- The University of Texas M.D. Anderson Cancer Center
- University of Alabama at Birmingham
- University of Bologna
- University of Bonn
- University of British Columbia
- University of Edinburgh
- University of Florida
- University of Heidelberg
- University of Illinois at Chicago
- University of Melbourne
- University of Michigan
- University of North Carolina at Chapel Hill
- University of Oxford
- University of Pisa
- University of Southern California
- University of Texas
- University of Turin
- University of Washington
- University of Würzburg
- Vanderbilt University School of Medicine
- Yale University School of Medicine
The database also includes pharmaceutical companies, biotech companies, CROs, hospitals, government labs and other organisations active in the Atypical Actives research field.
Sample companies in database include:
- ACADIA Pharmaceuticals, Inc
- Amgen Inc
- Animal Clinical Investigation, LLC
- Ascenta Therapeutics, Inc
- Astellas Pharma Inc
- Astra Arcus AB
- Banyu Pharmaceutical Co., Ltd
- BioMarin Pharmaceutical, Inc
- Biosystemix, Ltd
- Bristol-Myers Squibb Company
- Celgene Corporation
- Chiron Corporation
- Cognigen Corporation
- Corixa Corporation
- Eli Lilly and Company
- EPIDAUROS Biotechnologie AG
- F. Hoffmann-La Roche Ltd
- Forschungszentrum Karlsruhe GmbH
- Genentech Inc
- Hoffmann-La Roche Inc
- ICI Americas Inc
- IDEC Pharmaceuticals Corporation
- IMMUNE DISEASE INSTITUTE, INC
- Immunomedics, Inc
- IMRE Corporation
- Japan Science and Technology Corporation
- Kyowa Hakko Kogyo Co., Ltd
- Micromet AG
- Millennium Pharmaceuticals, Inc
- Nestec Ltd
- Neurogen Corporation
- Novartis Pharma AG
- Pfizer Inc
- Progenics Pharmaceuticals, Inc
- Seattle Genetics, Inc
- Sumitomo Pharmaceuticals Co., Ltd
- Taisho Pharmaceutical Co., Ltd
What is Maven:
- Largest database of international medical professionals, with over 6,000,000 people and over 500,000 medical organisations;
- All records are downloadable to excel or in-house database, with email, postal address and phone contacts;
- Profile and segment the entire database using over 47,000 diseases and therapeutic areas
For more information visit http://www.mavensemantic.com/